Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Radiation Injuries 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms, Male 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Radiotherapy 4Cisplatin 4Radiotherapy, Intensity-Modulated 2Radiosurgery 2Paclitaxel 2Donepezil 2Carboplatin 2Bevacizumab 2Amifostine 2sargramostim 1ethanethiol 1Vincristine 1Surgical Procedures, Operative 1Selenomethionine 1Salts 1Rituximab 1Radiation 1Procarbazine 1Oral Hygiene 1Neck Dissection 1Mometasone Furoate 1Methylprednisolone 1Methotrexate 1Magnetic Resonance Spectroscopy 1Lovastatin 1Fluorouracil 1Fibroblast Growth Factor 7 1Drug Therapy 1Cytarabine 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Radiation Injuries × Mometasone Furoate × Clear all
NCT00438659 2016-08-01

Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ

Alliance for Clinical Trials in Oncology

Phase 3 Completed
176 enrolled 10 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Radiation Injuries, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡